Complications in Hypertension and Obesity


Tracking Information

Start Date  ICMJEDecember 2007
Primary Completion Date 
Current Primary Outcome Measures  ICMJE 
 (submitted: December 28, 2007)		cardiovascular complications [ Time Frame: 2007-2017 ] [ Designated as safety issue: No ]
Original Primary Outcome Measures  ICMJE 
 (submitted: October 31, 2007)		cardiovascular complications [ Time Frame: 2007-2017 ]
Change HistoryComplete list of historical versions of study NCT00552292 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures  ICMJE 
 (submitted: December 28, 2007)		diabetes mellitus [ Time Frame: 2007-2017 ] [ Designated as safety issue: No ]
Original Secondary Outcome Measures  ICMJE 
 (submitted: October 31, 2007)		diabetes mellitus [ Time Frame: 2007-2017 ]

Descriptive Information

Brief Title  ICMJEComplications in Hypertension and Obesity
Official Title  ICMJENational Investigation of Cardiovascular Complications in Arterial Hypertension and Obesity
Brief Summary

The study in aimed to investigate epidemiology of risk factors in Russian Federation its prognostic value aimed on acceptance of national specific definition of metabolic syndrome and guidelines for its management.

Detailed Description 
Study Phase 
Study Type  ICMJEObservational
Study Design  ICMJECohort, Prospective
Condition  ICMJE
  • Metabolic Syndrome
  • Hypertension
  • Obesity
  • Dyslipidemia
  • Hyperglycemia
Intervention  ICMJE 

Recruitment Information

Estimated Enrollment  ICMJE30000
Estimated Completion DateJanuary 2017
Primary Completion Date 
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • Age older 18 years
  • Signed informed consent
  • Blood pressure more than 130 and/or 85 mm Hg
  • Waist circumference more than 80 sm in females and 94 in males and/or BMI more than 25 kg/m2
  • Dyslipidemia (elevated TG and/or decreased level of HDLP or therapy for high triglyceride level)
  • Fasting glucose more than 5,6 mmol/l

Exclusion Criteria:

  • Associated clinical conditions (stroke, TIA, MI, heart failure, renal disease, diabetes mellitus)
  • Severe concomitant diseases affecting outcome
GenderBoth
Ages18 Years to 90 Years
Accepts Healthy VolunteersNo
Contacts  ICMJE
Contact: Alexandra O Conrady, MD, PhD+7812-70255-71ahleague@mail.ru
Contact: Elena I Baranova, professor346-9082 ext +7812eibaranova@yahoo.com
Location Countries  ICMJERussian Federation

Administrative Information

NCT ID  ICMJENCT00552292
Responsible PartyShlyakhto Eugene, Almazov Federal Center of Heart, Blood and Endocrinology
Study ID Numbers  ICMJE25/1
Study Sponsor  ICMJEAlmazov Federal Center of Heart, Blood and Endocrinology
Collaborators  ICMJE 
Investigators  ICMJE
Study Director:Eugene V ShlyakhtoAlmazov Federal Center of Heart, Blood and Endocrinology
Information Provided ByAlmazov Federal Center of Heart, Blood and Endocrinology